GLP-1s and Pregnancy Planning: Clinical Guidance for Prescribers
GLP-1s and pregnancy planning is one of the more clinically clear-cut safety conversations in this drug class — and one that deserves a precise, unambiguous explanation rather than a vague caution.
The current clinical guidance
GLP-1 medications are generally not recommended during pregnancy, and prescribing guidance typically calls for discontinuation before actively attempting to conceive, with a washout period specific to the particular medication before pregnancy is attempted. This is standard guidance across the drug class based on limited safety data in pregnancy, not a policy specific to any individual provider.
What a thorough evaluation should screen for
- Current pregnancy or breastfeeding status
- Active attempts to conceive, or plans to within a clinically relevant timeframe
- Current contraception method, where relevant to the conversation
Care Bare Rx Custom
Ongoing clinician support that should include pregnancy-planning screening as part of standard evaluation.
Visit Care Bare Rx →Paid linkWhat patients planning to conceive should do
Raise pregnancy planning directly with your prescriber, even if it isn't explicitly asked — timing of discontinuation relative to conception attempts is a specific, individualized clinical conversation, not something to generalize from a blog post.
The clinical bottom line
This is exactly the kind of safety-critical information a prescriber needs accurate disclosure about to prescribe responsibly. Being upfront protects the patient, not just the provider — and any provider treating this as a routine checkbox rather than a genuine clinical conversation isn't meeting the standard this deserves.